Cullinan Therapeutics (CGEM) Minority Interest (2020 - 2023)

Cullinan Therapeutics' Minority Interest history runs 4 years deep, the most recent figure standing at $192000.0 for Q4 2023.

• In Q4 2023, Minority Interest changed N/A year-over-year to $192000.0; the TTM figure through Dec 2023 stood at $192000.0 (changed N/A YoY), while the FY2023 annual figure was $192000.0, changed N/A from the prior year.
• Minority Interest for Q4 2023 stood at $192000.0, up from $80000.0 in the prior quarter.
• The five-year high for Minority Interest was $3.0 million in Q2 2021, with the low at $80000.0 in Q2 2022.
• The 4-year median for Minority Interest is $1.3 million (2020), against an average of $1.4 million.
• The sharpest annual moves came in 2021 and 2022: Minority Interest soared 135.7% in 2021, then tumbled 97.33% in 2022.
• Cullinan Therapeutics' Minority Interest stood at $1.3 million in 2020, then slumped by 69.1% to $403000.0 in 2021, then slumped by 80.15% to $80000.0 in 2022, then jumped by 140.0% to $192000.0 in 2023.
• Business Quant data shows CGEM's Minority Interest at $192000.0 in Q4 2023, $80000.0 in Q2 2022, and $768000.0 in Q1 2022.